Psychedelics
Aaron Rodgers’ teammates appear to reference Packers QB’s ayahuasca use in TD celebration
Some of Aaron Rodgers’ teammates might have been paying attention to his very loud offseason. Near the end of the first half of “Sunday Night Football”…
Some of Aaron Rodgers’ teammates might have been paying attention to his very loud offseason.
Near the end of the first half of “Sunday Night Football” between the Green Bay Packers and Chicago Bears, the Packers quarterback found top returning receiver Allen Lazard for a four-yard touchdown pass.
As Lazard began his celebration, some members of the Packers offense — Randall Cobb, Aaron Jones, Jon Runyan, Yosh Nijman — grouped around him and mimed receiving something from the receiver, then playfully fell backward as though they were passing out.
As some Twitter users noted, it’s hard to not see the potential reference to Rodgers’ tales of hallucinogenic drugs last offseason:
Rodgers himself entered the impromptu huddle as some of his teammates flopped to the ground, but seemingly only to celebrate with Lazard as usual.
Rodgers made headlines during training camp when he recounted on a podcast how he took ayahuasca, a potent hallucinogen illegal in the United States, during a trip to Peru in the 2019 offseason. That drug use preceded back-to-back MVP seasons for Rodgers, which the quarterback claimed to not be a coincidence.
The admission triggered a miniature media circus (and massive spike in Google searches for ayahuasca), though it’s only another chapter in Rodgers’ recent habit of drawing attention for off-field reasons. At least his teammates are having fun with it.
The post Aaron Rodgers’ teammates appear to reference Packers QB’s ayahuasca use in TD celebration appeared first on REPORT DOOR.
ayahuasca hallucinogenic-
Psilocybin1 week ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics6 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
-
Psychedelics6 days ago
Cybin to Participate at the 27th Annual Milken Institute Global Conference
-
Psychedelics5 days ago
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
-
Law & Regulation4 days ago
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model
-
Ketamine5 days ago
DEA poised to move cannabis to Schedule III
-
Psychedelics5 days ago
Behold! A New Mushroom Emoji Has Arrived!
-
Psychedelics5 days ago
Behold! A New Mushroom Emoji Has Arrived!